These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11828745)

  • 21. Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Lange L; Kuhlmann RK
    Eur J Clin Pharmacol; 1992; 43(2):157-9. PubMed ID: 1425873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of Moisturizing Effect of Heparinoid Ointment (Hirudoid Soft Ointment) Diluted by White Petrolatum (Propeto)].
    Manabe H; Nozawa A; Matsumoto M; Ohtani M
    Yakugaku Zasshi; 2017; 137(6):763-766. PubMed ID: 28566581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release profiles of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments prepared by different mixing methods.
    Suzuki T; Uchino T; Miyazaki Y; Kagawa Y
    Chem Pharm Bull (Tokyo); 2012; 60(2):260-6. PubMed ID: 22293488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence (bioavailability) of generic topical corticosteroids.
    Jackson DB; Thompson C; McCormack JR; Guin JD
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):791-6. PubMed ID: 2715430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of urea in a topical corticoid preparation on vasoconstriction].
    Früh H
    Z Hautkr; 1983 Aug; 58(16):1203-5. PubMed ID: 6624181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Optimal measurement technic for the vasoconstrictor effect of corticosteroids. Comparative studies with reflection photometry and flow measurement].
    Gloor M; Sprenger HJ; Priebe L
    Dermatol Monatsschr; 1979 Sep; 165(9):665-9. PubMed ID: 527746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do local anesthetics have an influence on the percutaneous penetration of a model corticosteroid? An in vivo study using the vasoconstrictor assay.
    Römmen C; Leopold CS; Lippold BC
    Eur J Pharm Sci; 1999 Dec; 9(2):227-34. PubMed ID: 10620736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extemporaneous dilutions of proprietary topical corticosteroid preparations.
    Kirsch JM; Gibson JR; Darley C; Barrett CW
    Dermatologica; 1982 Jul; 165(1):71-2. PubMed ID: 7117653
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening of counterfeit corticosteroid in creams and ointments by NMR spectroscopy.
    McEwen I; Elmsjö A; Lehnström A; Hakkarainen B; Johansson M
    J Pharm Biomed Anal; 2012 Nov; 70():245-50. PubMed ID: 22846515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of the admixture of tetracycline and nadifloxacin ointments on their stability and their antibacterial activity].
    Kawamoto T; Tayama Y; Sawa A; Monde T; Sashima S; Yoshioka M; Miyake K; Morita S; Kihira K
    Yakugaku Zasshi; 2008 Aug; 128(8):1221-6. PubMed ID: 18670189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative vasoconstrictor assay for topical corticosteroids: the puzzling case of fluocinolone acetonide.
    Guin JD; Wallis MS; Walls R; Lehman PA; Franz TJ
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):197-202. PubMed ID: 8335738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The topical corticosteroid classification called into question: towards a new approach.
    Humbert P; Guichard A
    Exp Dermatol; 2015 May; 24(5):393-5. PubMed ID: 25707534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ranking of glucocorticoid creams and ointments.
    Poulsen J; Rorsman H
    Acta Derm Venereol; 1980; 60(1):57-62. PubMed ID: 6153835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams.
    Schwarz JS; Weisspapir MR; Friedman DI
    Pharm Res; 1995 May; 12(5):687-92. PubMed ID: 7479554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical corticosteroids: clinical pharmacology and therapeutic use.
    Miller JA; Munro DD
    Drugs; 1980 Feb; 19(2):119-34. PubMed ID: 7363838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of reflectance spectrophotometry in the human corticosteroid skin blanching assay.
    Conner DP; Zamani K; Almirez RG; Millora E; Nix D; Shah VP
    J Clin Pharmacol; 1993 Aug; 33(8):707-11. PubMed ID: 8408730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations.
    Gibson JR; Kirsch JM; Darley CR; Harvey SG; Burke CA; Hanson ME
    Br J Dermatol; 1984 Jul; 111 Suppl 27():204-12. PubMed ID: 6378245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the effective dose of a topical antifungal agent, omoconazole nitrate, on the basis of percutaneous pharmacokinetics in guinea-pigs and mice.
    Hashiguchi T; Ryu A; Itoyama T; Uchida K; Yamaguchi H
    J Pharm Pharmacol; 1997 Aug; 49(8):757-61. PubMed ID: 9379351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.